Increased P2RX4 expression was observed to also promote lysosomal exocytosis [55], allowing higher concentrations of CTSD to be released into the extracellular matrix, promoting degradation of the ECM and enhancing the invasive properties of cancer cells. Here, P2RX4 is linked to cancer.